Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis

Fig. 1

Early mitotic inhibitor 2 is overexpressed in cholangiocarcinoma. A The Venn diagram presents the overlap of the significantly upregulated genes (SUGs) between the GSE32225, GSE22633, and The Cancer Genome Atlas (TCGA) datasets; B The expression levels of EMI2 in various cancers in the TIMER database; C Paired and unpaired analysis of EMI2 based on TCGA database; D Western blotting was used to detect the expression of EMI2 in eight pairs of cholangiocarcinoma tissues; E Immunohistochemical analysis of tissue microarray revealed that EMI2 was upregulated in bile duct carcinoma; F Survival curves were grouped according to the expression levels of EMI2, in which red indicates the low-expression group and blue indicates the high-expression group (*P < 0.05; **P < 0.01; ***P < 0.001)

Back to article page